CVS Health Corp
NYSE:CVS
CVS Health Corp
NYSE:CVS
Price:
55.9 USD
1.36%
Market Closed
Updated:
May 4, 2024
CVS Health Corp
Cash from Financing Activities
|
CVS Health Corp
Cash from Financing Activities Peer Comparison
Comparables:
DVA
CHE
DGX
CI
LH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
-$1.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Chemed Corp
NYSE:CHE
|
Cash from Financing Activities
-$31.8m
|
CAGR 3-Years
51%
|
CAGR 5-Years
30%
|
CAGR 10-Years
13%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is CVS Health Corp's Cash from Financing Activities?
Cash from Financing Activities
-1.3B
USD
-1.3B
USD
Based on the financial report for Mar 31, 2024, CVS Health Corp's Cash from Financing Activities amounts to -1.3B USD.
What is CVS Health Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
0%
0%
Over the last year, the Cash from Financing Activities growth was 75%. The average annual Cash from Financing Activities growth rates for CVS Health Corp have been 55% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
